Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Market Study on Sterile Injectable Drugs: Cardiovascular Diseases Application Segment to Register a CAGR of 10.0% During 2016 - 2024

Published by Persistence Market Research Product code 487447
Published Content info 249 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Market Study on Sterile Injectable Drugs: Cardiovascular Diseases Application Segment to Register a CAGR of 10.0% During 2016 - 2024
Published: January 23, 2017 Content info: 249 Pages
Description

In its new publication titled "Sterile Injectable Drugs Market: Global Industry Analysis and Forecast, 2016-2024," Persistence Market Research explains how companies in the global sterile injectable drugs market are mainly focusing on geographic expansion by establishing facilities in proximity to target markets and consolidation of existing manufacturing capabilities to gain larger market share. This eight year forecast of the global sterile injectable drugs market further points out that big pharmaceutical companies acquiring firms in the Asia Pacific region are expected to strengthen market position and create sustainable positioning. Persistence Market Research differentiates the strategies of key players and highlights that companies across the globe are focusing on strengthening their position through acquisitions and are developing manufacturing capabilities to achieve economies of scale. Moreover, market players are targeting North America and Europe by launching patent protected and complex biologics in the global sterile injectable drugs market.

While researching this report, the team of analysts have found out that North America, Europe and Asia Pacific regions are target markets for major players operating in the global sterile injectable drugs market. According to the report, the bulging products pipeline for parenteral administration, a conducive business environment in developing economies, the surge in local production of generic injectable drugs and presence of a large patient pool are promising factors for investors to invest in the aforementioned regions. The report also covers an analysis of the supply chain operations and commercialization of the global sterile injectable drugs market.

Primarily, the report presents an overview of the global sterile injectable drugs market. This is followed by the market taxonomy and a section that underlines the various factors influencing the growth of the global sterile injectable drugs market. Yearly change in inflation rate has not been factored while forecasting market numbers. Top-down approach has been used to calculate market forecast, while bottom-up approach by therapeutic areas has been used to counter-validate market numbers. Indicators such as R&D expenditure, research funding from government and non-profit organizations etc. have been considered to arrive at the indicated market numbers.

A section of the report covers the global sterile injectable drugs market performance in terms of revenue contribution from various segments. This section also includes Persistence Market Research's analysis of key trends, drivers, restraints and opportunities, which are influencing the growth of the global sterile injectable drugs market. Impact analysis of key regional growth drivers and restraints based on the weighted average model along with key region-specific trends is included in the report to better equip clients with information and hidden insights. Finally, Persistence Market Research also provides key strategic recommendations for both existing and new players in the global sterile injectable drugs market to emerge sustainably profitable.

Global Sterile Injectable Drugs Market Segmentation:

  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • MEA
  • By Drug Type
    • Monoclonal Antibodies
    • Cytokines
    • Insulin
    • Peptide Hormones
    • Blood Factors
    • Vaccines
    • Immunoglobulins
    • Peptide Antibiotics
    • Others
  • By Application
    • Cancer
    • Diabetes
    • Cardiovascular Diseases
    • Musculoskeletal
    • CNS
    • Infections
    • Others
  • By Route of Administration
    • Intravenous (IV)
    • Intramuscular (IM)
    • Subcutaneous (SC)
    • Others
  • By Molecule Type
    • Small Molecules
    • Large Molecules
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Exclusive Research Methodology:

Persistence Market Research analysts have carried out in-depth secondary research to ascertain overall market size, top industry players, and top products. The team of analysts has further conducted extensive interviews with industry experts, industry players, retailers and distributors based on a comprehensive discussion guide formulated by Persistence Market Research. Data so gathered is validated using the triangulation method, wherein secondary research (consisting of company websites, their annual reports, white papers and financial reports), primary research and Persistence Market Research's analysis contributes to the final data. The analysts have also considered paid publications such as Factiva, GBI, Genios, and Meltwater while researching the global sterile injectable drugs market.

Market Examination Based on Key Growth Parameters:

It is imperative to note that in an ever-fluctuating global economy, the report not only conducts forecasts in terms of CAGR but also analyzes the market on the basis of key parameters such as Year-on-Year (Y-o-Y) growth to understand the predictability of the market and to identify the right opportunities likely to emerge in the global sterile injectable drugs market. Another feature of this report is an analysis of all key segments of the global sterile injectable drugs market and their revenue forecast in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global sterile injectable drugs market. Further, in order to understand key market segments in terms of growth and performance in the global sterile injectable drugs market, Persistence Market Research has developed a market attractiveness index to help providers identify real market opportunities.

Table of Contents

Table of Contents

1. Executive Summary

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Global Sterile Injectable Drugs Market Analysis Scenario

  • 3.1. Market Size (US$ Bn) and Forecast
    • 3.1.1. Market Size and Y-o-Y Growth
    • 3.1.2. Absolute $ Opportunity
  • 3.2. Market Overview
    • 3.2.1. Value Chain

4. Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
    • 4.2.1. Supply Side
    • 4.2.2. Demand Side
  • 4.3. Restraints
  • 4.4. Opportunity
  • 4.5. Forecast Factors - Relevance and Impact
  • 4.6. Patent Expiries

5. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Molecules

  • 5.1. Introduction
  • 5.2. Basis Point Share (BPS) Analysis By Molecules Type
  • 5.3. Y-o-Y Growth Projections By Molecules Type
  • 5.4. Market Value Forecast By Molecules, 2016-2024
    • 5.4.1. Large Molecules
    • 5.4.2. Small Molecules
  • 5.5. Market Attractiveness By Molecules

6. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Drugs

  • 6.1. Introduction
  • 6.2. Basis Point Share (BPS) Analysis By Drugs
  • 6.3. Y-o-Y Growth Projections By Drugs
  • 6.4. Market Value Forecast By Drugs , 2016-2024
    • 6.4.1. Monoclonal Antibodies (Mabs)
    • 6.4.2. Cytokines
    • 6.4.3. Insulin
    • 6.4.4. Peptide Hormones
    • 6.4.5. Vaccines
    • 6.4.6. Immunoglobulins
    • 6.4.7. Blood Factors
    • 6.4.8. Peptide Antibiotics
    • 6.4.9. Others
  • 6.5. Market Attractiveness By Drugs

7. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Application

  • 7.1. Introduction
  • 7.2. Basis Point Share (BPS) Analysis By Application
  • 7.3. Y-o-Y Growth Projections By Application
  • 7.4. Market Value Forecast By Application, 2016-2024
    • 7.4.1. Cancer
    • 7.4.2. Diabetes
    • 7.4.3. Cardiovascular Diseases
    • 7.4.4. Musculoskeletal
    • 7.4.5. CNS
    • 7.4.6. Infections
    • 7.4.7. Others
  • 7.5. Market Attractiveness By Application

8. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Route of Administration

  • 8.1. Introduction
  • 8.2. Basis Point Share (BPS) Analysis By Route of Administration
  • 8.3. Y-o-Y Growth Projections By Route of Administration
  • 8.4. Market Value Forecast By Route of Administration, 2016-2024
    • 8.4.1. Intravenous (IV)
    • 8.4.2. Intramuscular (IM)
    • 8.4.3. Subcutaneous (SC)
    • 8.4.4. Others
  • 8.5. Market Attractiveness By Route of Administration

9. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Distribution Channel

  • 9.1. Introduction
  • 9.2. Basis Point Share (BPS) Analysis By Distribution Channel
  • 9.3. Y-o-Y Growth Projections By Distribution Channel
  • 9.4. Market Value Forecast By Distribution Channel , 2019-2024
    • 9.4.1. Hospitals Pharmacies
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Online Pharmacies
  • 9.5. Market Attractiveness By Distribution Channel

10. Global Sterile Injectable Drugs Market Analysis and Forecasts, By Region

  • 10.1. Basis Point Share (BPS) Analysis By Region
  • 10.2. Y-o-Y Growth Projections By Region
  • 10.3.Market Value Forecast By Region
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. APEJ
    • 10.3.5. MEA
  • 10.4.Market Attractiveness By Region

11. North America Sterile Injectable Drugs Market Analysis and Forecast

  • 11.1.Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
  • 11.2.Market Value Forecast By Molecules, 2016-2024
    • 11.2.1. Large Molecules
    • 11.2.2. Small Molecules
  • 11.3.Market Value Forecast By Distribution Channel , 2016-2024
    • 11.3.1. Hospitals Pharmacies
    • 11.3.2. Retail Pharmacies
    • 11.3.3. Online Pharmacies
  • 11.4.Market Value Forecast By Drugs , 2016-2024
    • 11.4.1. Monoclonal Antibodies (Mabs)
    • 11.4.2. Cytokines
    • 11.4.3. Insulin
    • 11.4.4. Peptide Hormones
    • 11.4.5. Vaccines
    • 11.4.6. Immunoglobulins
    • 11.4.7. Blood Factors
    • 11.4.8. Peptide Antibiotics
    • 11.4.9. Others
  • 11.5.Market Value Forecast By Application, 2016-2024
    • 11.5.1. Cancer
    • 11.5.2. Diabetes
    • 11.5.3. Cardiovascular Diseases
    • 11.5.4. Musculoskeletal
    • 11.5.5. CNS
    • 11.5.6. Infections
    • 11.5.7. Others
  • 11.6.Market Value Forecast By Route of Administration, 2016-2024
    • 11.6.1. Intravenous (IV)
    • 11.6.2. Intramuscular (IM)
    • 11.6.3. Subcutaneous (SC)
    • 11.6.4. Others
  • 11.7.Market Value Forecast By Country, 2016-2024
    • 11.7.1. US
    • 11.7.2. Canada
  • 11.8.Market Attractiveness Analysis
    • 11.8.1. By Molecules
    • 11.8.2. By Distribution Channel
    • 11.8.3. By Drugs
    • 11.8.4. By Application
    • 11.8.5. By Route of Administration
    • 11.8.6. By Country
  • 11.9. Prominent Trends

12. Latin America Sterile Injectable Drugs Market Analysis and Forecast

  • 12.1.Introduction
    • 12.1.1. Basis Point Share (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
  • 12.2.Market Value Forecast By Molecules, 2016-2024
    • 12.2.1. Large Molecules
    • 12.2.2. Small Molecules
  • 12.3.Market Value Forecast By Distribution Channel , 2016-2024
    • 12.3.1. Hospitals Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Online Pharmacies
  • 12.4.Market Value Forecast By Drugs , 2016-2024
    • 12.4.1. Monoclonal Antibodies (Mabs)
    • 12.4.2. Cytokines
    • 12.4.3. Insulin
    • 12.4.4. Peptide Hormones
    • 12.4.5. Vaccines
    • 12.4.6. Immunoglobulins
    • 12.4.7. Blood Factors
    • 12.4.8. Peptide Antibiotics
    • 12.4.9. Others
  • 12.5.Market Value Forecast By Application, 2016-2024
    • 12.5.1. Cancer
    • 12.5.2. Diabetes
    • 12.5.3. Cardiovascular Diseases
    • 12.5.4. Musculoskeletal
    • 12.5.5. CNS
    • 12.5.6. Infections
    • 12.5.7. Others
  • 12.6.Market Value Forecast By Route of Administration, 2016-2024
    • 12.6.1. Intravenous (IV)
    • 12.6.2. Intramuscular (IM)
    • 12.6.3. Subcutaneous (SC)
    • 12.6.4. Others
  • 12.7.Market Value Forecast By Country, 2016-2024
    • 12.7.1. Brazil
    • 12.7.2. Mexico
    • 12.7.3. Rest of Latin America
  • 12.8.Market Attractiveness Analysis
    • 12.8.1. By Molecules
    • 12.8.2. By Distribution Channel
    • 12.8.3. By Drugs
    • 12.8.4. By Application
    • 12.8.5. By Route of Administration
    • 12.8.6. By Country
  • 12.9. Prominent Trends

13. Europe Sterile Injectable Drugs Market Analysis and Forecast

  • 13.1.Introduction
    • 13.1.1. Basis Point Share (BPS) Analysis By Country
    • 13.1.2. Y-o-Y Growth Projections By Country
  • 13.2.Market Value Forecast By Molecules, 2016-2024
    • 13.2.1. Large Molecules
    • 13.2.2. Small Molecules
  • 13.3.Market Value Forecast By Distribution Channel , 2016-2024
    • 13.3.1. Hospitals Pharmacies
    • 13.3.2. Retail Pharmacies
    • 13.3.3. Online Pharmacies
  • 13.4.Market Value Forecast By Drugs , 2016-2024
    • 13.4.1. Monoclonal Antibodies (Mabs)
    • 13.4.2. Cytokines
    • 13.4.3. Insulin
    • 13.4.4. Peptide Hormones
    • 13.4.5. Vaccines
    • 13.4.6. Immunoglobulins
    • 13.4.7. Blood Factors
    • 13.4.8. Peptide Antibiotics
    • 13.4.9. Others
  • 13.5.Market Value Forecast By Application, 2016-2024
    • 13.5.1. Cancer
    • 13.5.2. Diabetes
    • 13.5.3. Cardiovascular Diseases
    • 13.5.4. Musculoskeletal
    • 13.5.5. CNS
    • 13.5.6. Infections
    • 13.5.7. Others
  • 13.6.Market Value Forecast By Route of Administration, 2016-2024
    • 13.6.1. Intravenous (IV)
    • 13.6.2. Intramuscular (IM)
    • 13.6.3. Subcutaneous (SC)
    • 13.6.4. Others
  • 13.7.Market Value Forecast By Country, 2016-2024
    • 13.7.1. UK
    • 13.7.2. France
    • 13.7.3. Germany
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Russia
    • 13.7.7. Rest of Europe
  • 13.8.Market Attractiveness Analysis
    • 13.8.1. By Molecules
    • 13.8.2. By Distribution Channel
    • 13.8.3. By Drugs
    • 13.8.4. By Application
    • 13.8.5. By Route of Administration
    • 13.8.6. By Country
  • 13.9. Prominent Trends

14. APEJ Sterile Injectable Drugs Market Analysis and Forecast

  • 14.1.Introduction
    • 14.1.1. Basis Point Share (BPS) Analysis By Country
    • 14.1.2. Y-o-Y Growth Projections By Country
  • 14.2.Market Value Forecast By Molecules, 2016-2024
    • 14.2.1. Large Molecules
    • 14.2.2. Small Molecules
  • 14.3.Market Value Forecast By Distribution Channel , 2016-2024
    • 14.3.1. Hospitals Pharmacies
    • 14.3.2. Retail Pharmacies
    • 14.3.3. Online Pharmacies
  • 14.4.Market Value Forecast By Drugs , 2016-2024
    • 14.4.1. Monoclonal Antibodies (Mabs)
    • 14.4.2. Cytokines
    • 14.4.3. Insulin
    • 14.4.4. Peptide Hormones
    • 14.4.5. Vaccines
    • 14.4.6. Immunoglobulins
    • 14.4.7. Blood Factors
    • 14.4.8. Peptide Antibiotics
    • 14.4.9. Others
  • 14.5.Market Value Forecast By Application, 2016-2024
    • 14.5.1. Cancer
    • 14.5.2. Diabetes
    • 14.5.3. Cardiovascular Diseases
    • 14.5.4. Musculoskeletal
    • 14.5.5. CNS
    • 14.5.6. Infections
    • 14.5.7. Others
  • 14.6.Market Value Forecast By Route of Administration, 2016-2024
    • 14.6.1. Intravenous (IV)
    • 14.6.2. Intramuscular (IM)
    • 14.6.3. Subcutaneous (SC)
    • 14.6.4. Others
  • 14.7.Market Value Forecast By Country, 2016-2024
    • 14.7.1. Japan
    • 14.7.2. China
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. ASEAN
    • 14.7.6. Rest of APAC
  • 14.8.Market Attractiveness Analysis
    • 14.8.1. By Molecules
    • 14.8.2. By Distribution Channel
    • 14.8.3. By Drugs
    • 14.8.4. By Application
    • 14.8.5. By Route of Administration
    • 14.8.6. By Country
  • 14.9. Prominent Trends

15. MEA Sterile Injectable Drugs Market Analysis and Forecast

  • 15.1.Introduction
    • 15.1.1. Basis Point Share (BPS) Analysis By Country
    • 15.1.2. Y-o-Y Growth Projections By Country
  • 15.2.Market Value Forecast By Molecules, 2016-2024
    • 15.2.1. Large Molecules
    • 15.2.2. Small Molecules
  • 15.3.Market Value Forecast By Distribution Channel , 2016-2024
    • 15.3.1. Hospitals Pharmacies
    • 15.3.2. Retail Pharmacies
    • 15.3.3. Online Pharmacies
  • 15.4.Market Value Forecast By Drugs , 2016-2024
    • 15.4.1. Monoclonal Antibodies (Mabs)
    • 15.4.2. Cytokines
    • 15.4.3. Insulin
    • 15.4.4. Peptide Hormones
    • 15.4.5. Vaccines
    • 15.4.6. Immunoglobulins
    • 15.4.7. Blood Factors
    • 15.4.8. Peptide Antibiotics
    • 15.4.9. Others
  • 15.5.Market Value Forecast By Application, 2016-2024
    • 15.5.1. Cancer
    • 15.5.2. Diabetes
    • 15.5.3. Cardiovascular Diseases
    • 15.5.4. Musculoskeletal
    • 15.5.5. CNS
    • 15.5.6. Infections
    • 15.5.7. Others
  • 15.6.Market Value Forecast By Route of Administration, 2016-2024
    • 15.6.1. Intravenous (IV)
    • 15.6.2. Intramuscular (IM)
    • 15.6.3. Subcutaneous (SC)
    • 15.6.4. Others
  • 15.7.Market Value Forecast By Country, 2016-2024
    • 15.7.1. GCC Countries
    • 15.7.2. South Africa
    • 15.7.3. North Africa
    • 15.7.4. Rest of MEA
  • 15.8.Market Attractiveness Analysis
    • 15.8.1. By Molecules
    • 15.8.2. By Distribution Channel
    • 15.8.3. By Drugs
    • 15.8.4. By Application
    • 15.8.5. By Route of Administration
    • 15.8.6. By Country
  • 15.9. Prominent Trends

16. Competition Landscape

  • 16.1. Competition Dashboard
  • 16.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 16.2.1. Baxter International Inc.
    • 16.2.2. Sanofi
    • 16.2.3. Pfizer Inc.
    • 16.2.4. GlaxoSmithKline plc.
    • 16.2.5. AstraZeneca
    • 16.2.6. GILEAD SCIENCES, INC.
    • 16.2.7. Merck & Co., Inc.
    • 16.2.8. Novartis AG
    • 16.2.9. Johnson & Johnson Services, Inc.
    • 16.2.10. Nova Nordisk A/S

17. Assumptions and Acronyms Used

18. Research Methodology

List of Tables

  • Table 01: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015-2024
  • Table 02: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 03: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015-2024
  • Table 04: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015-2024
  • Table 05: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015-2024
  • Table 06: Global Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Region, 2015-2024
  • Table 07: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015-2024
  • Table 08: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015-2024
  • Table 09: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 10: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015-2024
  • Table 11: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015-2024
  • Table 12: North America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel,
  • Table 13: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015-2024
  • Table 14: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015-2024
  • Table 15: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 16: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015-2024
  • Table 17: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015-2024
  • Table 18: Latin America Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel,
  • Table 19: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015-2024
  • Table 20: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015-2024
  • Table 21: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 22: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015-2024
  • Table 23: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015-2024
  • Table 24: Europe Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015-2024
  • Table 25: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015-2024
  • Table 26: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015-2024
  • Table 27: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 28: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015-2024
  • Table 29: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015-2024
  • Table 30: APAC Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015-2024
  • Table 31: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Country, 2015-2024
  • Table 32: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Molecule Type, 2015-2024
  • Table 33: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Drug Type, 2015-2024
  • Table 34: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Application Type, 2015-2024
  • Table 35: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Routes of Administration, 2015-2024
  • Table 36: MEA Sterile Injectable Drugs Market Value (US$ Bn) Analysis and Forecast By Distribution Channel, 2015-2024

List of Figures

  • Figure 01: Global Sterile Injectable Drugs Market - Scenario Forecast, 2016-2024 (US$ Bn)
  • Figure 02 : Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 03 : Global Sterile Injectable Drugs Market Absolute $ Opportunity, 2016-2024
  • Figure 04 : Global Sterile Injectable Drugs Market Share Analysis (%) By Molecule Type, 2016 & 2024
  • Figure 05 : Global Sterile Injectable Drugs Y-o-Y growth (%) By Molecule Type, 2016-2024
  • Figure 06: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Small Molecules Segment,

2015-2024

  • Figure 07: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Small Molecules Segment, 2016-2024
  • Figure 08: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Large Molecules Segment,

2015-2024

  • Figure 09: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Large Molecules Segment, 2016-2024
  • Figure 10: Global Sterile Injectable Drugs Market Attractiveness Analysis By Molecule Type, 2016-2024
  • Figure 11: Global Sterile Injectable Drugs Market Share Analysis (%) By Drug Type, 2016 & 2024
  • Figure 12: Global Sterile Injectable Drugs Y-o-Y growth (%) By Drug Type, 2016-2024
  • Figure 13: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Monoclonal Antibodies (mAbs)

Segment, 2015-2024

  • Figure 14: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Monoclonal Antibodies (mAbs) Segment,

2016-2024

  • Figure 15: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cytokines Segment, 2015-2024
  • Figure 16: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cytokines Segment, 2016-2024
  • Figure 17: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Insulin Segment, 2015-2024
  • Figure 18: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Insulin Segment, 2016-2024
  • Figure 19: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Peptide Hormones Segment,

2015-2024

  • Figure 20: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Peptide Hormones Segment, 2016-2024
  • Figure 21: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) Vaccines Segment, 2015-2024
  • Figure 22: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Vaccines Segment, 2016-2024
  • Figure 23: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Immunoglobulins Segment,

2015-2024

  • Figure 24: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Immunoglobulins Segment, 2016-2024
  • Figure 25: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Blood Factors Segment,

2015-2024

  • Figure 26: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Blood Factors Segment, 2016-2024
  • Figure 27: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Peptide Antibiotics Segment,

2015-2024

  • Figure 28: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Peptide Antibiotics Segment, 2016-2024
  • Figure 29: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015-2024
  • Figure 30: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016-2024
  • Figure 31: Global Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 32: Global Sterile Injectable Drugs Market Share Analysis (%) By Application, 2016 & 2024
  • Figure 33: Global Sterile Injectable Drugs Y-o-Y growth (%) By Application, 2016-2024
  • Figure 34: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cancer Segment, 2015-2024
  • Figure 35: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cancer Segment, 2016-2024
  • Figure 36: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Diabetes Segment, 2015-2024
  • Figure 37: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Diabetes Segment, 2016-2024
  • Figure 38: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Cardiovascular Diseases Segment,

2015-2024

  • Figure 39: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Cardiovascular Diseases Segment, 2016-2024
  • Figure 40: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Musculoskeletal Segment,

2015-2024

  • Figure 41: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Musculoskeletal Segment, 2016-2024
  • Figure 42: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By CNS Segment, 2015-2024
  • Figure 43: Global Sterile Injectable Drugs Market Absolute $ Opportunity By CNS Segment, 2016-2024
  • Figure 44: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Infections Segment, 2015-2024
  • Figure 45: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Infections Segment, 2016-2024
  • Figure 46: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015-2024
  • Figure 47: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016-2024
  • Figure 48: Global Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016-2024
  • Figure 49: Global Sterile Injectable Drugs Market Share Analysis (%) By Routes of Administration, 2016 & 2024
  • Figure 50: Global Sterile Injectable Drugs Y-o-Y growth (%) By Routes of Administration, 2016-2024
  • Figure 51: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Intravenous (IV) Segment,

2015-2024

  • Figure 52: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Intravenous (IV) Segment, 2016-2024
  • Figure 53: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Intramuscular (IM) Segment, 2015-2024
  • Figure 54: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Intramuscular (IM) Segment, 2016-2024
  • Figure 55: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Subcutaneous (SC) Segment, 2015-2024
  • Figure 56: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Subcutaneous (SC) Segment, 2016-2024
  • Figure 57: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Others Segment, 2015-2024
  • Figure 58: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Others Segment, 2016-2024
  • Figure 59: Global Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016-2024
  • Figure 60: Global Sterile Injectable Drugs Market Share Analysis (%) By Distribution Channel, 2016 & 2024
  • Figure 61: Global Sterile Injectable Drugs Y-o-Y growth (%) By Distribution Channel, 2016-2024
  • Figure 62: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Hospital Pharmacies Segment, 2015-2024
  • Figure 63: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Hospital Pharmacies Segment, 2016-2024
  • Figure 64: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Retail Pharmacies Segment, 2015-2024
  • Figure 65: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Retail Pharmacies Segment, 2016-2024
  • Figure 66: Global Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%) By Online Pharmacies Segment, 2015-2024
  • Figure 67: Global Sterile Injectable Drugs Market Absolute $ Opportunity By Online Pharmacies Segment, 2016-2024
  • Figure 68: Global Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 69: Global Sterile Injectable Drugs Market Share Analysis (%) By Region, 2016 & 2024
  • Figure 70: Global Sterile Injectable Drugs Y-o-Y growth (%) By Region, 2016-2024
  • Figure 71: North America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 72: North America Sterile Injectable Drugs Market Absolute $ Opportunity, 2016-2024
  • Figure 73: Latin America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 74: Latin America Sterile Injectable Drugs Market Absolute $ Opportunity, 2016-2024
  • Figure 75: Europe Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 76: Europe Sterile Injectable Drugs Market Absolute $ Opportunity, 2016-2024
  • Figure 77: APAC Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 78: APAC Sterile Injectable Drugs Market Absolute $ Opportunity, 2016-2024
  • Figure 79: MEA Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 80: MEA Sterile Injectable Drugs Market Absolute $ Opportunity, 2016-2024
  • Figure 81: Global Sterile Injectable Drugs Market Attractiveness Analysis By Region, 2016-2024
  • Figure 82: North America Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 83: North America Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016-2024
  • Figure 84: U.S. Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 85: U.S. Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 86: Canada Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 87: Canada Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016-2024
  • Figure 88: North America Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016-2024
  • Figure 89: North America Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016-2024
  • Figure 90: North America Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 91: North America Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016-2024
  • Figure 92: North America Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016-2024
  • Figure 93: North America Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 94: Latin America Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 95: Latin America Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016-2024
  • Figure 96: Brazil Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 97: Brazil Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 98: Mexico Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 99: Mexico Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 100: Rest of Latin America Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 101: Rest of Latin America Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 102: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016-2024
  • Figure 103: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016-2024
  • Figure 104: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 105: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016-2024
  • Figure 106: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016-2024
  • Figure 107: Latin America Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 108: Europe Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 109: Europe Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016-2024
  • Figure 110: Germany Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 111: Germany Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 112: France Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 113: France Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 114: Russia Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 115: Russia Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 116: Italy Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 117: Italy Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 118: Spain Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 119: Spain Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 120: U.K. Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 121: U.K. Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 122: Rest of Europe Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 123: Rest of Europe Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 124: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016-2024
  • Figure 125: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016-2024
  • Figure 126: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 127: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016-2024
  • Figure 128: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016-2024
  • Figure 129: Europe Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 130: APAC Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 131: APAC Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016-2024
  • Figure 132: China Sterile Injectable Drugs Market Value
  • Figure 133: China Sterile Injectable Drugs Market Absolute $ Opportunity (US$), 2016-2024
  • Figure 134: India Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 135: India Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 136: Japan Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 137: Japan Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 138: Australia & New Zealand Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 139: Australia & New Zealand Sterile Injectable Drugs Market Absolute $ Opportunity, 2016-2024
  • Figure 140: ASEAN Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 141: ASEAN Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 142: Rest of APAC Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 143: Rest of APAC Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 144: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016-2024
  • Figure 145: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016-2024
  • Figure 146: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 147: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016-2024
  • Figure 148: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016-2024
  • Figure 149: APAC Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016-2024
  • Figure 150: MEA Sterile Injectable Drugs Market Share Analysis (%) By Country, 2016 & 2024
  • Figure 151: MEA Sterile Injectable Drugs Y-o-Y growth (%) By Country, 2016-2024
  • Figure 152: GCC Countries Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 153: GCC Countries Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn), 2016-2024
  • Figure 154: South Africa Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 155: South Africa Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016-2024
  • Figure 156: North Africa Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 157: North Africa Sterile Injectable Drugs Market Absolute $ Opportunity (US$ Bn) 2016-2024
  • Figure 158: Rest of MEA Sterile Injectable Drugs Market Value (US$ Bn) & Y-o-Y Growth (%), 2015-2024
  • Figure 159: Rest of MEA Sterile Injectable Drugs Market Absolute $ Opportunity (US$), 2016-2024
  • Figure 160: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Country, 2016-2024
  • Figure 161: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Molecule type, 2016-2024
  • Figure 162: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Drug Type, 2016-2024
  • Figure 163: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Application Type, 2016-2024
  • Figure 164: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Routes of Administration, 2016-2024
  • Figure 165: MEA Sterile Injectable Drugs Market Attractiveness Analysis By Distribution Channel, 2016-2024
Back to Top